ITI is a program of The Task Force for Global Health.
Central African Republic
Trachoma has been known as a public health problem in CAR since the 1970s. Surveys in 10 of the 16 regions around this time confirmed elevated rates of trachoma. The trachoma program is housed within National Blindness Prevention Program.
The most recent surveys in CAR were conducted from 2008-2011 in 8 of the 16 regions, with support from CDC, ITI and CBM. A TAP was completed in 2011.
The CAR civil war, which began in late 2012, has significantly affected trachoma programming. The first shipment of Zithromax® to CAR arrived in March 2013 one day before the capital, Bangui, fell to rebels. Roughly 850,000/4.6 million (almost 1 in 5!) Central Africans have been displaced since the start of the conflict, both within CAR and into neighboring countries, likely impacting transmission of trachoma. Conflict has prevented MDAs and baseline surveys from happening, as the conditions were too dangerous. MDA did not begin until 2015, when the security situation had finally improved enough to start treatment in one region of the country.
CURRENT IMPLEMENTATION STATUS
In 2016, CAR achieved 100% administrative coverage, conducting MDA in all four approved regions. This is the first time the program has been able to achieve this. The program is optimistic about its ability to scale up to seven regions in 2017. The program hopes to map more regions in 2017, security circumstances permitting. While conflict remains a reality, the program is extremely resourceful and eager to eliminate trachoma in CAR.
Zithromax® Shipments by Year